| Product Name | Cantuzumab | 
|---|---|
| CAS | 400010-39-1 | 
| Storage condition | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles | 
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity | 
|---|---|---|---|---|
| 1 mg | 3-5days | ¥8500.00 | Visible after login | |
| 5 mg | 3-5days | ¥30000.00 | Visible after login | 
| Product Name | Cantuzumab | 
|---|---|
| CAS | 400010-39-1 | 
| Storage condition | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles | 
Cantuzumab mertansine (SB-408075; huC242-DM1), an ADC, is an immunoconjugate of the potent maytansine derivative (DM1; HY-19792) and the humanized monoclonal antibody (huC242) directed to CanAg. Cantuzumab mertansine has cytotoxic toward colon cancer cells and has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts.